These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 3533178

  • 41. Successful unrelated marrow transplantation for patients over the age of 40 with chronic myelogenous leukemia.
    Drobyski WR, Pelz C, Kabler-Babbitt C, Hessner M, Baxter-Lowe LA, Keever-Taylor CA.
    Biol Blood Marrow Transplant; 1998; 4(1):3-12. PubMed ID: 9701386
    [Abstract] [Full Text] [Related]

  • 42. [Current status of allogenic bone marrow transplantation in chronic myelocytic leukemia].
    Speck B, Gratwohl A, Osterwalder B, Nissen C, Buser U, Reusser P, Tichelli A, Würsch A, Jeannet M.
    Schweiz Med Wochenschr; 1984 Oct 06; 114(40):1377-9. PubMed ID: 6387902
    [Abstract] [Full Text] [Related]

  • 43. Allogeneic marrow transplantation for chronic granulocytic leukemia.
    Fefer A, Clift RA, Thomas ED.
    J Natl Cancer Inst; 1986 Jun 06; 76(6):1295-9. PubMed ID: 3520071
    [Abstract] [Full Text] [Related]

  • 44. Percentage of Philadelphia chromosome (Ph)-negative and Ph-positive cells found after autologous transplantation for chronic myelogenous leukemia depends on percentage of diploid cells induced by conventional-dose chemotherapy before collection of autologous cells.
    Talpaz M, Kantarjian H, Liang J, Calvert L, Hamer J, Tibbits P, Durett A, Claxton D, Giralt S, Khouri I.
    Blood; 1995 Jun 01; 85(11):3257-63. PubMed ID: 7756658
    [Abstract] [Full Text] [Related]

  • 45. Allogeneic bone marrow transplantation for leukaemia in Europe. Report from the Working Party on Leukaemia, European Group for Bone Marrow Transplantation.
    Lancet; 1988 Jun 18; 1(8599):1379-82. PubMed ID: 2898053
    [Abstract] [Full Text] [Related]

  • 46. Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival.
    Kantarjian HM, Smith TL, McCredie KB, Keating MJ, Walters RS, Talpaz M, Hester JP, Bligham G, Gehan E, Freireich EJ.
    Blood; 1985 Dec 18; 66(6):1326-35. PubMed ID: 3864497
    [Abstract] [Full Text] [Related]

  • 47. Philadelphia-positive metaphases in the marrow after bone marrow transplantation for chronic granulocytic leukemia.
    Apperley JF, Rassool F, Parreira A, Geary CG, Harrison C, Stansfield D, Goldman JM.
    Am J Hematol; 1986 Jun 18; 22(2):199-204. PubMed ID: 3518418
    [Abstract] [Full Text] [Related]

  • 48. Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group.
    Ravindranath Y, Yeager AM, Chang MN, Steuber CP, Krischer J, Graham-Pole J, Carroll A, Inoue S, Camitta B, Weinstein HJ.
    N Engl J Med; 1996 May 30; 334(22):1428-34. PubMed ID: 8618581
    [Abstract] [Full Text] [Related]

  • 49. HLA-identical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission duration.
    Martin PJ, Clift RA, Fisher LD, Buckner CD, Hansen JA, Appelbaum FR, Doney KC, Sullivan KM, Witherspoon RP, Storb R.
    Blood; 1988 Dec 30; 72(6):1978-84. PubMed ID: 3058233
    [Abstract] [Full Text] [Related]

  • 50. Unrelated donor bone marrow transplantation as treatment for chronic myeloid leukemia: the Spanish experience. The Chronic Myeloid Leukemia Subcommittee of the GETH. Grupo Español de Trasplante Hemopoyético.
    Carreras E, Tomás JF, Sanz G, Iriondo A, Boqué C, López J, Cabrera R, Sureda A, de Soria VG, Sierra J, Sanz MA, Torres A.
    Haematologica; 2000 May 30; 85(5):530-8. PubMed ID: 10800172
    [Abstract] [Full Text] [Related]

  • 51. Comparison of genomic DNA and cDNA for detection of residual disease after treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation.
    Zhang JG, Lin F, Chase A, Goldman JM, Cross NC.
    Blood; 1996 Mar 15; 87(6):2588-93. PubMed ID: 8630427
    [Abstract] [Full Text] [Related]

  • 52. [Bone marrow transplantation in chronic myeloid leukemia. Influence of gnotobiotic measures, especially antiviral prophylaxis].
    Ostendorf P, Ehninger G, Schmidt H, Haen M, Link H, Schüch K, Müller C, Wernet P, Dopfer H, Klingebiel T.
    Dtsch Med Wochenschr; 1986 Feb 14; 111(7):259-63. PubMed ID: 3004881
    [Abstract] [Full Text] [Related]

  • 53. Factors influencing survival in Philadelphia chromosome positive chronic myelocytic leukemia.
    Oguma S, Takatsuki K, Uchino H, Kamada N, Oguma N, Kuramoto A.
    Cancer; 1982 Dec 15; 50(12):2928-34. PubMed ID: 6958355
    [Abstract] [Full Text] [Related]

  • 54. Parameters of Predictive Value in Chronic Myeloid Leukemia-The Prognostic Impact of Histopathological Variables in a Multivariate Regression Analysis.
    Thiele J, Kvasnicka HM, Zankovich R, Fischer R, Diehl V.
    Leuk Lymphoma; 1991 Dec 15; 4(1):63-74. PubMed ID: 27462719
    [Abstract] [Full Text] [Related]

  • 55. Cytogenetic correlation with disease status and treatment outcome in advanced stage leukemia post bone marrow transplantation: a Southwest Oncology Group study (SWOG-8612).
    Slovak ML, Kopecky KJ, Wolman SR, Henslee-Downey JP, Appelbaum FR, Forman SJ, Blume KG.
    Leuk Res; 1995 Jun 15; 19(6):381-8. PubMed ID: 7596150
    [Abstract] [Full Text] [Related]

  • 56. Bone marrow transplantation for chronic granulocytic leukemia.
    Lehn P, Devergie A, Benbunan M, Lemercier N, Raffoux C, Rabian C, Vilmer E, Azogui O, Irti T, Gluckman E.
    J Natl Cancer Inst; 1986 Jun 15; 76(6):1301-5. PubMed ID: 3520072
    [Abstract] [Full Text] [Related]

  • 57. Chromosome studies in patients with Philadelphia chromosome-positive chronic myeloid leukemia submitted to bone marrow transplantation--results of a European Cooperative Study.
    Zaccaria A, Rosti G, Testoni N, Alimena G, Arcese W, Bandini G, Boogaerts M, Carbonell F, Ferrant A, Filippetti A.
    Cancer Genet Cytogenet; 1987 May 15; 26(1):5-13. PubMed ID: 3548945
    [Abstract] [Full Text] [Related]

  • 58. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia.
    Hansen JA, Gooley TA, Martin PJ, Appelbaum F, Chauncey TR, Clift RA, Petersdorf EW, Radich J, Sanders JE, Storb RF, Sullivan KM, Anasetti C.
    N Engl J Med; 1998 Apr 02; 338(14):962-8. PubMed ID: 9521984
    [Abstract] [Full Text] [Related]

  • 59. T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation.
    Drobyski WR, Hessner MJ, Klein JP, Kabler-Babbitt C, Vesole DH, Margolis DA, Keever-Taylor CA.
    Blood; 1999 Jul 15; 94(2):434-41. PubMed ID: 10397710
    [Abstract] [Full Text] [Related]

  • 60. Bone marrow transplantation of chronic myelogenous leukemia in chronic phase: evaluation of risks and benefits.
    Wagner JE, Zahurak M, Piantadosi S, Geller RB, Vogelsang GB, Wingard JR, Saral R, Griffin C, Shah N, Zehnbauer BA.
    J Clin Oncol; 1992 May 15; 10(5):779-89. PubMed ID: 1569450
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.